PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Qiu, H.L.* ; Fan, S.* ; Zhou, K.* ; He, Z.* ; Browning, M.H.E.M.* ; Knibbs, L.D.* ; Zhao, T. ; Luo, Y.N.* ; Liu, X.X.* ; Hu, L.X.* ; Li, J.X.* ; Zhang, Y.D.* ; Xie, Y.T.* ; Heinrich, J. ; Dong, G.H.* ; Yang, B.Y.*

Global burden and drivers of hyperglycemia: Estimates and predictions from 1990 to 2050.

Innovation 4:100450 (2023)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Hyperglycemia is a key risk factor for death and disability worldwide. To better inform prevention strategies, we aimed to delineate and predict the temporal, spatial, and demographic patterns in mean fasting plasma glucose (FPG) levels and their related disease burden globally. Based on the Global Burden of Disease Study 2019, we estimated the distributions of mean FPG levels and high FPG-related disease burden by age, sex, year, socioeconomic status (SES), and geographical region from 1990 to 2050. We also investigated the possible associations of demographic, behavioral, dietary, metabolic, and environmental factors with FPG levels and high FPG-related disease burden. In 2019, the global mean FPG level was 5.40 mmol/L (95% uncertainty interval [UI]: 4.86-6.00), and high FPG contributed to 83.0 deaths (95% UI, 64.5-107.1) and 2,104.3 DALYs (95% UI: 1,740.7-2,520.7) per 100,000 people. For both historical (1990-2019) and future (2020-2050) periods, the mean FPG levels and the high FPG-related disease burden increased globally, with greater increases among the middle-aged and elderly, and people in low-to-middle SES countries, relative to their counterparts. Aging, unhealthy lifestyles, elevated body mass index, and lower air temperatures were potential risk factors for high FPG levels and the high FPG-related disease burden. This study demonstrates that high FPG continues to contribute to the global disease burden and is expected to do so for at least the next 30 years. Older people and those living in low-to-middle SES countries should receive more attention in glycemic management health interventions. In addition, effective interventions that target identified risk factors should be adopted to handle the increasingly large disease burden of high FPG.
Impact Factor
Scopus SNIP
Altmetric
33.100
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Fasting Plasma-glucose; Type-2; Prevention; Projections; Obesity; Stress; Risk
Sprache englisch
Veröffentlichungsjahr 2023
HGF-Berichtsjahr 2023
ISSN (print) / ISBN 2666-6758
e-ISSN 2666-6758
Zeitschrift Innovation
Quellenangaben Band: 4, Heft: 4, Seiten: , Artikelnummer: 100450 Supplement: ,
Verlag Zeiss
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504000-008
Förderungen Central Public -interest Scienti fic Institution Basal Research Fund of South China Institute of Environmental Sciences
National Natural Science Foundation of China
National Key Research and Development Program of China
DOI 10.1016/j.xinn.2023.100450
WOS ID 001026621500001
Scopus ID 85161984189
PubMed ID 37485083
Erfassungsdatum 2023-10-06
[➜Korrektur melden]